| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (CN6 + coagulase-negative + methicillin-susceptible) |
- |
- |
2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox)  |
207 |
| Staphylococci (CN6 + coagulase-negative + methicillin-susceptible) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
207 |
| Staphylococci (CN6 + coagulase-negative + methicillin-susceptible) |
- |
- |
8 － ? |
Teicoplanin (Targocid) |
207 |
| Staphylococci (coagulase negative + methicillin-resistant) |
>0.015 |
>128 |
≤0.008 － >128 |
Rifampicin (Rifampin) |
178 |
| Staphylococci (coagulase negative + methicillin-resistant) |
0.5 |
1 |
0.5 － 4 |
Quinupristin/Dalfopristin (Synercid) |
178 |
| Staphylococci (coagulase negative + methicillin-resistant) |
1 |
4 |
0.25 － 4 |
RWJ-5442 |
178 |
| Staphylococci (coagulase negative + methicillin-resistant) |
16 |
32 |
1 － 32 |
Teicoplanin (Targocid) |
178 |
| Staphylococci (coagulase negative + methicillin-resistant) |
32 |
128 |
0.03 － 64 |
Gentamicin (Gentamycin, Garamycin) |
178 |
| Staphylococci (coagulase negative + methicillin-susceptible) |
0.015 |
0.03 |
≤0.008 － 4 |
Rifampicin (Rifampin) |
178 |
| Staphylococci (coagulase negative + methicillin-susceptible) |
0.125 |
4 |
0.03 － 128 |
Gentamicin (Gentamycin, Garamycin) |
178 |
| Staphylococci (coagulase negative + methicillin-susceptible) |
0.25 |
1 |
≤0.06 － 1 |
RWJ-5442 |
178 |
| Staphylococci (coagulase negative + methicillin-susceptible) |
0.5 |
1 |
0.25 － 1 |
Quinupristin/Dalfopristin (Synercid) |
178 |
| Staphylococci (coagulase negative + methicillin-susceptible) |
1 |
16 |
0.25 － 32 |
Teicoplanin (Targocid) |
178 |
| Staphylococci (coagulase negative + methicillin-susceptible) |
2 |
4 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
178 |
| Staphylococci (coagulase-negativ) |
>2 |
>4 |
≤0.12 － >4 |
Levofloxacin (Levaquin, Quixin) |
1130 |
| Staphylococci (coagulase-negative + 1990-1994) |
0.06 |
0.12 |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
163 |
| Staphylococci (coagulase-negative + 1990-1994) |
0.06 |
0.19 |
? － ? |
Gatifloxacin (Tequin) |
163 |
| Staphylococci (coagulase-negative + 1990-1994) |
0.19 |
1 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
163 |
| Staphylococci (coagulase-negative + 1990-1994) |
0.19 |
4 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
163 |
| Staphylococci (coagulase-negative + 1990-1994) |
0.38 |
4 |
? － ? |
Ofloxacin (Floxin) |
163 |
| Staphylococci (coagulase-negative + 1990-2004) |
0.09 |
32 |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
163 |
| Staphylococci (coagulase-negative + 1990-2004) |
0.19 |
32 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
163 |
| Staphylococci (coagulase-negative + 1990-2004) |
0.19 |
32 |
? － ? |
Gatifloxacin (Tequin) |
163 |
| Staphylococci (coagulase-negative + 1990-2004) |
0.25 |
32 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
163 |
| Staphylococci (coagulase-negative + 1990-2004) |
0.5 |
32 |
? － ? |
Ofloxacin (Floxin) |
163 |
| Staphylococci (coagulase-negative + 1995-1999) |
0.09 |
4 |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
163 |
| Staphylococci (coagulase-negative + 1995-1999) |
0.19 |
4 |
? － ? |
Gatifloxacin (Tequin) |
163 |
| Staphylococci (coagulase-negative + 1995-1999) |
0.19 |
4 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
163 |